Nexalis Therapeutics Ltd (NX1, formerly Inhalerx Limited), is an Australian Clinical Stage Drug Development Company that is developing onset, inhaled therapies to address unmet medical needs in pain management and mental health sectors.
Find out what a historical investment in Nexalis Therapeutics would be worth today using our NX1 stock calculator.
Buying NX1 shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Nexalis Therapeutics in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in NX1
What is the ticker symbol of Nexalis Therapeutics?
The ticker symbol for Nexalis Therapeutics is NX1.
How much is one share of NX1?
One share of NX1 is valued at $0.01 as of 20 November 2026.
What is the market capitalisation of Nexalis Therapeutics NX1?
As of 20 November 2026 Nexalis Therapeutics has a market cap of $2.02M.
What is the P/E ratio of NX1?
The Price to Earnings ratio of NX1 is -1.07.
What is the Earnings Per Share of NX1?
The Earnings Per Share of NX1 is -$0.01.
What is the 52-week high for Nexalis Therapeutics stock?
The Nexalis Therapeutics 52-week high stock price is $0.04.
What is the 52-week low for Nexalis Therapeutics stock?
The Nexalis Therapeutics 52-week low stock price is $0.01.
Can I buy NX1 shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy NX1 shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.